Delivery Order SPE2DB22D3010-SPE2DB24FP2XX

Award Date 7/29/24
Potential Completion Date 7/30/24
Potential Value $18K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order valued at $2,530.62 to Amerisourcebergen Drug Corp, Corporate Office Division, for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML pharmaceutical products. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to provide a comprehensive range of medical commodities in support of military treatment programs and...
The Defense Logistics Agency (DLA) awarded a $7,298.44 firm fixed price delivery order to Amerisourcebergen Drug Corp's Corporate Office division for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML pharmaceutical products. This order falls under a larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. As a major...
The Defense Logistics Agency (DLA) has awarded a $5,431.64 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025, which serves as Amerisourcebergen's primary contract vehicle for delivering...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corporation's Corporate Office Division a $7,256.75 firm-fixed-price delivery order contract for the pharmaceutical product OZEMPIC 1MG/0.75ML. This order was placed under Amerisourcebergen's existing $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical and medical supplies to DLA facilities...
The Defense Logistics Agency (DLA) awarded a $3,568.65 firm-fixed price delivery order contract to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml. This delivery order was placed under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical division. The contract, which does not have a set-aside designation, has an ultimate completion date of October 16, 2024. As a major...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $4,780.11 to the prime contractor Amerisourcebergen Drug Corp. The contract is for the pharmaceutical product OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML and has an ultimate completion date of March 21, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $6,985.70 firm fixed price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a pharmaceutical product, with a performance period through August 5, 2024. AmerisourceBergen is a major supplier of pharmaceutical and medical products to the federal government, including the military, with multiple Indefinite Delivery Contracts...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the corporate office division of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,129.08 contract is for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML pharmaceuticals, with a completion date of February 13, 2024. Amerisourcebergen Drug Corp is the prime contractor on a $999,999,999.00 indefinite delivery...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $8,528.49 to Amerisourcebergen Drug Corp for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML. The contract has an ultimate completion date of August 1, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is providing these essential medical supplies through its corporate office division. This contract is associated with a larger Indefinite Delivery Contract (IDC) valued up to...
The Defense Logistics Agency (DLA) awarded a $3,287.16 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml pharmaceutical product. The contract has an ultimate completion date of May 15, 2024. Amerisourcebergen Drug Corp holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, which...
  • SPE2DB22D3010
    Indefinite Delivery Contract
  • SPE2DB22D3010-SPE2DB24FP2XX
    Delivery Order

The Defense Logistics Agency (DLA) awarded a $17,973.50 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office division for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML pharmaceutical products. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has no set-aside designation and is set to be completed by July 30, 2024. As one of the largest pharmaceutical distributors in the U.S., Amerisourcebergen leverages its extensive supply chain network to deliver essential medications and medical supplies to various federal agencies and healthcare programs.

Generated 10/28/24, 9:46 AM